UPMC Cancer Center Passavant (OHA)

Pittsburgh, Pennsylvania 15237

We've found

1 trials

at this facility

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Pittsburgh, PA

Use our guide to learn which trials are right for you!